Transcend Capital Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $2.68M | Buy |
|
|||||
|
2025
Q2 | $2.67M | Sell |
|
|||||
|
2025
Q1 | $6.16M | Sell |
|
|||||
|
2024
Q4 | $11.1M | Sell |
|
|||||
|
2024
Q3 | $10.3M | Sell |
|
|||||
|
2024
Q2 | $8.35M | Buy |
|
|||||
|
2024
Q1 | $10.7M | Buy |
|
|||||
|
2023
Q4 | $8.29M | Buy |
|
|||||
|
2023
Q3 | $7.18M | Sell |
|
|||||
|
2023
Q2 | $8.04M | Sell |
|
|||||
|
2023
Q1 | $8.95M | Buy |
|
|||||
|
2022
Q4 | $9.26M | Sell |
|
|||||
|
2022
Q3 | $9.4M | Buy |
|
|||||
|
2022
Q2 | $9.96M | Sell |
|
|||||
|
2022
Q1 | $9.47M | Buy |
|
|||||
|
2021
Q4 | $8M | Sell |
|
|||||
|
2021
Q3 | $7.53M | Sell |
|
|||||
|
2021
Q2 | $10.8M | Buy |
|
|||||
|
2021
Q1 | $10.1M | Sell |
|
|||||
|
2020
Q4 | $10.2M | Sell |
|
|||||
|
2020
Q3 | $11.5M | Sell |
|
|||||
|
2020
Q2 | $11.4M | Sell |
|
|||||
|
2020
Q1 | $11.3M | Sell |
|
|||||
|
2019
Q4 | $13M | Buy |
|